牛流行熱ワクチンの世界市場

牛流行熱ワクチンの世界市場は2030年までに8,280万米ドルに達する見込み

2024年に7,480万米ドルと推定される牛流行熱ワクチンの世界市場は、2024～2030年の分析期間においてCAGR 1.7%で成長し、2030年には8,280万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである生ワクチンは、CAGR 1.4%を記録し、分析期間終了時には4,410万米ドルに達すると予測されます。キルドワクチン分野の成長率は、分析期間中CAGR 2.0％と推定されます。

米国市場は2,040万米ドルと推定、中国はCAGR 3.4％で成長予測

米国の牛流行熱ワクチン市場は、2024年に2,040万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1,530万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは3.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ0.6％と1.2％と予測されています。欧州では、ドイツがCAGR約0.8%で成長すると予測されています。

世界の牛流行熱ワクチン市場- 主要動向と促進要因まとめ

なぜ牛流行熱ワクチン接種は家畜の健康と農場の収益にとって重要なのか？

牛流行熱（BEF）は、一般的に三日病として知られ、特に熱帯・亜熱帯地域で家畜の健康に大きな影響を与えるウイルス性疾患です。突然の発熱、硬直、跛行、食欲不振が特徴で、通常は数日で治りますが、乳量の減少、体重減少、一時的な不妊、獣医費用の増加により、深刻な経済的損失につながる可能性があります。場合によっては合併症により死亡することもあり、特に高齢の動物や傷つきやすい動物では注意が必要です。ワクチン接種はBEFに対する最も効果的な予防戦略として登場し、牛群全体を保護し、生産性の中断を最小限に抑えます。この病気は蚊やコバエなどの刺す昆虫によって媒介されるため、季節的・地域的な発生を予測することは難しく、流行地域ではワクチン接種が不可欠です。感染地域の畜産農家は、牛群の健康を守り、食肉や酪農生産から安定した収入を確保するために、先制予防接種の重要性を認識しつつあります。人獣共通感染症とその経済的影響に対する認識の高まりとともに、食糧安全保障に対する需要の高まりは、動物ワクチン接種プログラムの緊急性をさらに浮き彫りにしています。牛流行熱ワクチンは、弱毒生ワクチンであれ不活化ワクチンであれ、疾病の発生を抑え、牛群全体の回復力を向上させる費用対効果の高い手段を提供します。農法が近代化し、商業畜産が世界的に規模を拡大するにつれ、ワクチン接種は疾病管理と畜産経営計画の不可欠な一部となりつつあります。

ワクチン開発の進歩は、牛黄熱に対する防御をどのように強化しているのでしょうか？

最近のワクチン技術の革新により、ワクチンの有効性、安全性、保存性が大幅に向上しています。従来、弱毒生ワクチンは広く使用され、強力な免疫応答をもたらしたが、安定性や免疫不全動物におけるリスクについて懸念されることもありました。不活化ウイルス製剤やサブユニットベースのオプションを含む新世代のワクチンは、副作用の少ないより安全な代替ワクチンを提供することで、これらの課題に対処しています。これらの製剤は、輸送やコールドチェーンのロジスティクスが困難な地域では特に有用です。分子生物学的研究により、BEFウイルスの構造と抗原性成分の理解が深まり、標的を絞ったワクチン設計や診断適合性の向上への道が開かれつつあります。一部の製造業者は、生きたウイルスを使用せずに抗原を製造する組換えDNA技術を研究しており、これによりバイオセーフティ基準を改善し、アウトブレイクに対応した迅速な製造サイクルを可能にしています。さらに、アジュバント技術も進化し、免疫反応を高め、防御期間を延長することで、頻繁な再接種の必要性を減らしています。また、1回の接種で複数の牛の病原体を予防する多価ワクチンの調査も進んでおり、利便性と幅広い疾病対象が提供されています。このような技術的進歩により、BEFワクチンは様々な気候や耕作条件に適応できるようになり、媒介性牛疫をより効果的に制御するための世界の取り組みを支援しています。データ分析、デジタルヘルスモニタリング、獣医用モバイルアプリケーションの統合は、予防接種スケジュールと遵守率をさらに改善し、予防接種プログラムの全体的な効果を高めています。

世界のBEFワクチン需要に影響を与える地域・環境要因は？

牛流行熱ワクチンの需要は、気候、牛の人口密度、農法、病気の流行などの違いにより、地域によって大きく異なります。BEFはアジア、アフリカ、オーストラリア、中東の一部で最も流行しており、温暖で湿度が高く、ウイルスを媒介する昆虫ベクターにとって理想的な条件が揃っています。オーストラリアでは、BEFの流行は歴史的に北部と東部でよく見られ、そのため官民の獣医療サービスによるワクチン接種プログラムが広まっています。インドネシア、タイ、フィリピンなどの東南アジア諸国でも季節的な流行が報告されており、政府主導の意識向上キャンペーンやワクチン接種への補助金が実施されています。畜産が主要な生計手段であるアフリカでは、BEFの流行は散発的ではあるが深刻で、農村部の農家は流通の課題や限られたインフラのためにワクチンへのアクセスに苦労することが多いです。サウジアラビアやイランを含む中東諸国は、気候変動による疾病圧力の影響を受けやすい成長中の酪農・肉牛部門を守るため、BEFワクチンの接種に力を入れています。ラテンアメリカでは、この病気の流行は少ないもの、国境を越える動物疾病に対する懸念が高まっているため、BEFをより広範な動物衛生サーベイランスシステムに組み入れることが求められています。気温の上昇や降水パターンの変化などの環境変化は、昆虫媒介動物の地理的範囲を拡大し、BEFを新たな地域に持ち込む可能性があり、以前は影響を受けていなかった地域での予防ワクチン接種を促しています。厳しい家畜衛生規制を持つ国々は、国境を越えた牛の移動にワクチン接種証明書を義務付けており、輸出志向の農業経済圏でのワクチン接種をさらに促しています。

世界の牛流行熱ワクチン市場の成長を促進する主な要因とは？

牛流行熱ワクチン市場の成長は、疾病の蔓延、家畜数の増加、ワクチン製剤の進歩、獣医学インフラの拡大などの組み合わせによってもたらされます。主な要因のひとつは、BEFの発生に伴う経済的リスク、特に乳量の減少、繁殖力の低下、治療費の増加に対する農家や畜産業者の意識の高まりです。食肉と乳製品に対する世界の需要が増加し続ける中、生産者は健康で生産性の高い牛群を維持する必要に迫られており、疾病予防を最優先事項としています。政府の政策や獣医保健プログラムも、補助金や意識向上キャンペーン、リスクの高い地域での予防接種の義務化を通じてワクチン接種を促進することにより、極めて重要な役割を果たしています。特にアジア太平洋とアフリカの一部では、商業的畜産が拡大し、より優れたコールドチェーン物流と流通網に支えられて、動物用ワクチンの市場が拡大しています。単回投与レジメンや耐熱性製剤のようなワクチン供給における革新は、酪農家による利用しやすさとコンプライアンスをさらに向上させています。さらに、動物衛生データシステムの統合が進んでいるため、より正確な疾病追跡、早期警報アラート、戦略的ワクチン配備が可能となっています。アニマルバイオテクノロジーへの民間セクターの投資や、獣医学的健康に関する国際的な共同研究は、より競合的で革新的な市場情勢に寄与しています。これらの要因が相まって、牛流行熱ワクチンの需要は持続的に増加しており、世界の家畜衛生管理と農業生産性向上の重要な要素となっています。

セグメント

タイプ（生ワクチン、キルドワクチン、その他のタイプ）、用途（牛用、水牛用）、エンドユーザー（医療機器企業、製薬、動物病院、その他のエンドユーザー）

調査対象企業の例

• Bayer AG
• Biogenesis Bago
• Bioveta a.s.
• Boehringer Ingelheim Animal Health
• Ceva Sante Animale
• China Animal Husbandry Industry
• Elanco Animal Health
• Fatro S.p.A.
• Hester Biosciences Limited
• HIPRA
• Indian Immunologicals Ltd.
• Intervet（MSD Animal Health）
• Kyoto Biken Laboratories Inc.
• Laboratorios Ovejero S.A.
• Merck & Co., Inc.（MSD AH）
• Norbrook Laboratories
• Phibro Animal Health Corporation
• Vaxxinova
• Vetoquinol
• Zoetis Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Bovine Ephemeral Fever Vaccines Market to Reach US$82.8 Million by 2030

The global market for Bovine Ephemeral Fever Vaccines estimated at US$74.8 Million in the year 2024, is expected to reach US$82.8 Million by 2030, growing at a CAGR of 1.7% over the analysis period 2024-2030. Live Vaccine, one of the segments analyzed in the report, is expected to record a 1.4% CAGR and reach US$44.1 Million by the end of the analysis period. Growth in the Killed Vaccine segment is estimated at 2.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$20.4 Million While China is Forecast to Grow at 3.4% CAGR

The Bovine Ephemeral Fever Vaccines market in the U.S. is estimated at US$20.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$15.3 Million by the year 2030 trailing a CAGR of 3.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.6% and 1.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 0.8% CAGR.

Global Bovine Ephemeral Fever Vaccines Market - Key Trends & Drivers Summarized

Why Is Bovine Ephemeral Fever Vaccination Critical for Livestock Health and Farm Profitability?

Bovine ephemeral fever (BEF), commonly known as three-day sickness, is a viral disease that significantly impacts cattle health, particularly in tropical and subtropical regions. Characterized by sudden fever, stiffness, lameness, and loss of appetite, the disease typically resolves within a few days but can lead to severe economic losses due to reduced milk production, weight loss, temporary infertility, and increased veterinary costs. In some cases, complications can even result in death, especially in older or more vulnerable animals. Vaccination has emerged as the most effective preventive strategy against BEF, offering protection to entire herds and minimizing productivity disruptions. Given that the disease is transmitted by biting insects such as mosquitoes and midges, its seasonal and regional outbreaks can be hard to predict, making vaccination essential in endemic zones. Livestock farmers in affected areas are increasingly recognizing the importance of preemptive immunization to safeguard herd health and ensure stable income from meat and dairy production. The rising demand for food security, along with growing awareness of zoonotic diseases and their economic implications, further highlights the urgency for robust animal vaccination programs. Bovine ephemeral fever vaccines, whether live attenuated or inactivated, provide a cost-effective tool for reducing disease incidence and improving overall herd resilience. As farming practices modernize and commercial livestock production scales up globally, vaccination is becoming an integral part of disease management and operational planning for cattle-rearing operations.

How Are Advancements in Vaccine Development Enhancing Protection Against Bovine Ephemeral Fever?

Recent innovations in vaccine technology are significantly improving the efficacy, safety, and shelf-life of bovine ephemeral fever vaccines. Traditionally, live attenuated vaccines were widely used, offering strong immune responses but sometimes raising concerns about stability and risk in immunocompromised animals. New-generation vaccines, including inactivated virus formulations and subunit-based options, are addressing these challenges by providing safer alternatives with minimal side effects. These formulations are particularly valuable in regions where transportation and cold-chain logistics are difficult, as advancements in thermostable vaccines reduce the need for constant refrigeration. Molecular research has also led to a better understanding of the BEF virus structure and antigenic components, paving the way for targeted vaccine design and improved diagnostic compatibility. Some manufacturers are exploring recombinant DNA techniques to produce antigens without using the live virus, thereby improving biosafety standards and enabling faster production cycles in response to outbreaks. Additionally, adjuvant technologies have evolved to enhance the immune response and prolong the duration of protection, reducing the need for frequent re-vaccinations. Research into multivalent vaccines that protect against multiple bovine pathogens in a single dose is also gaining ground, offering convenience and broader disease coverage. These technological strides are making BEF vaccines more adaptable to varied climatic and farming conditions, supporting global efforts to control vector-borne cattle diseases more effectively. The integration of data analytics, digital health monitoring, and veterinary mobile applications is further improving vaccination schedules and compliance rates, enhancing the overall impact of immunization programs.

What Regional and Environmental Factors Influence the Demand for BEF Vaccines Worldwide?

The demand for bovine ephemeral fever vaccines varies significantly across regions due to differences in climate, cattle population density, farming practices, and disease prevalence. BEF is most prevalent in parts of Asia, Africa, Australia, and the Middle East, where warm temperatures and high humidity provide ideal conditions for the insect vectors that transmit the virus. In Australia, BEF outbreaks have been historically common in the northern and eastern regions, leading to widespread vaccination programs supported by both public and private veterinary services. Southeast Asian nations like Indonesia, Thailand, and the Philippines also report seasonal outbreaks, prompting government-led awareness campaigns and subsidies for vaccine access. In Africa, where livestock farming is a major livelihood, BEF outbreaks are sporadic but severe, with rural farmers often struggling to access vaccines due to distribution challenges and limited infrastructure. Middle Eastern countries, including Saudi Arabia and Iran, have increased their focus on BEF vaccination to protect growing dairy and beef sectors that are vulnerable to climate-induced disease pressures. In Latin America, the disease is less prevalent but growing concerns about transboundary animal diseases have prompted inclusion of BEF in broader animal health surveillance systems. Environmental changes, including rising temperatures and altered precipitation patterns, are expanding the geographical range of insect vectors, potentially introducing BEF into new regions and prompting preventive vaccination in previously unaffected areas. Regional trade dynamics also influence vaccine demand, as countries with strict livestock health regulations require vaccination certificates for cross-border cattle movements, further incentivizing vaccination uptake in export-oriented farming economies.

What Are the Main Factors Driving the Growth of the Bovine Ephemeral Fever Vaccines Market Globally?

The growth in the bovine ephemeral fever vaccines market is driven by a combination of rising disease prevalence, increasing livestock populations, advancements in vaccine formulation, and expanding veterinary infrastructure. One of the primary factors is the growing awareness among farmers and livestock producers about the economic risks associated with BEF outbreaks, particularly in terms of lost milk yield, reduced fertility, and higher treatment costs. As the global demand for meat and dairy products continues to rise, producers are under increasing pressure to maintain healthy and productive herds, making disease prevention a top priority. Government policies and veterinary health programs are also playing a pivotal role by promoting vaccination through subsidies, awareness campaigns, and mandatory immunization initiatives in high-risk areas. The expansion of commercial livestock farming, especially in Asia-Pacific and parts of Africa, has created a larger market for animal vaccines, supported by better cold-chain logistics and distribution networks. Innovations in vaccine delivery, such as single-dose regimens and thermostable formulations, are further enhancing accessibility and compliance among farmers. In addition, the growing integration of animal health data systems allows for more accurate disease tracking, early warning alerts, and strategic vaccine deployment. Private sector investment in animal biotechnology and international collaborations on veterinary health research are contributing to a more competitive and innovative market landscape. Collectively, these factors are fueling a sustained increase in demand for bovine ephemeral fever vaccines, positioning them as a critical component of global livestock health management and agricultural productivity enhancement.

SCOPE OF STUDY:

The report analyzes the Bovine Ephemeral Fever Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Live Vaccine, Killed Vaccine, Other Types); Application (Cattle Application, Water Buffaloes Application); End-User (Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Bayer AG
• Biogenesis Bago
• Bioveta a.s.
• Boehringer Ingelheim Animal Health
• Ceva Sante Animale
• China Animal Husbandry Industry
• Elanco Animal Health
• Fatro S.p.A.
• Hester Biosciences Limited
• HIPRA
• Indian Immunologicals Ltd.
• Intervet (MSD Animal Health)
• Kyoto Biken Laboratories Inc.
• Laboratorios Ovejero S.A.
• Merck & Co., Inc. (MSD AH)
• Norbrook Laboratories
• Phibro Animal Health Corporation
• Vaxxinova
• Vetoquinol
• Zoetis Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Bovine Ephemeral Fever Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Outbreak Incidence Throws the Spotlight on Bovine Ephemeral Fever Vaccine Deployment
  • Rising Economic Impact of BEF on Dairy and Beef Cattle Spurs Demand for Preventive Vaccination Programs
  • Here's the Story: How Climate Change and Vector Spread Are Expanding the Geographical Risk Zone for BEF
  • Government-Led Livestock Immunization Campaigns Strengthen Business Case for BEF Vaccine Adoption
  • Growth of Commercial Dairy Farms and Export-Oriented Livestock Sectors Expands Addressable Market for BEF Vaccines
  • Here's How Advances in Adjuvant and Recombinant Vaccine Technologies Are Enhancing BEF Vaccine Efficacy
  • Global Focus on Livestock Health Security Throws the Spotlight on Zoonotic and Vector-Borne Disease Control Measures
  • Rising Cross-Border Animal Movement Sustains Need for Preemptive Immunization Against Outbreak Risk
  • Integration of BEF Vaccination into Multi-Disease Control Strategies Generates Demand for Combination Vaccines
  • Increasing Pressure to Reduce Antibiotic Use in Livestock Promotes Preventive Approaches Like Vaccination
  • Expansion of Cold Chain Logistics Enhances Vaccine Reach in Remote and Climatically Challenging Areas
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Bovine Ephemeral Fever Vaccines Market Analysis of Annual Sales in US$ for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Bovine Ephemeral Fever Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Live Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Live Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Live Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Killed Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Killed Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Killed Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Cattle Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Cattle Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Cattle Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Water Buffaloes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Water Buffaloes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Water Buffaloes Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Medical Device Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Medical Device Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Medical Device Companies End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Pharmaceutical End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Pharmaceutical End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Pharmaceutical End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Animal Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Animal Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Animal Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Bovine Ephemeral Fever Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 40: USA 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 49: Canada 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• JAPAN
  • Bovine Ephemeral Fever Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 58: Japan 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• CHINA
  • Bovine Ephemeral Fever Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 64: China 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 67: China 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• EUROPE
  • Bovine Ephemeral Fever Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Bovine Ephemeral Fever Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• FRANCE
  • Bovine Ephemeral Fever Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 85: France 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 88: France 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• GERMANY
  • Bovine Ephemeral Fever Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 97: Germany 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 106: Italy 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Bovine Ephemeral Fever Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 112: UK 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 115: UK 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 124: Spain 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 133: Russia 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Bovine Ephemeral Fever Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Bovine Ephemeral Fever Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Bovine Ephemeral Fever Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 163: Australia 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• INDIA
  • Bovine Ephemeral Fever Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 169: India 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 172: India 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 181: South Korea 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Bovine Ephemeral Fever Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Bovine Ephemeral Fever Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 211: Argentina 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 220: Brazil 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 229: Mexico 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Bovine Ephemeral Fever Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Bovine Ephemeral Fever Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 259: Iran 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 268: Israel 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 286: UAE 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030
• AFRICA
  • Bovine Ephemeral Fever Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Bovine Ephemeral Fever Vaccines by Type - Live Vaccine, Killed Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Type - Percentage Breakdown of Value Sales for Live Vaccine, Killed Vaccine and Other Types for the Years 2014, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Bovine Ephemeral Fever Vaccines by Application - Cattle Application and Water Buffaloes Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for Bovine Ephemeral Fever Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application and Water Buffaloes Application for the Years 2014, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Bovine Ephemeral Fever Vaccines by End-user - Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 304: Africa 16-Year Perspective for Bovine Ephemeral Fever Vaccines by End-user - Percentage Breakdown of Value Sales for Medical Device Companies End-User, Pharmaceutical End-User, Animal Hospitals End-User and Other End-Users for the Years 2014, 2025 & 2030

IV. COMPETITION